Infiltrative hepatocellular carcinoma (HCC), also known as diffuse hepatocellular carcinoma, is an infrequent subtype of HCC, which has particular imaging characteristics. Because of these characteristics, it has been called cirrhotomimetic HCC or cirrhosis-like HCC.
On this page:
Epidemiology
Infiltrative hepatocellular carcinomas account for ~15% (range 13-20%) or less of HCC cases and are reportedly often associated with hepatitis B ref.
Radiographic features
In contrast to the nodular or massive HCC subtypes, infiltrative HCC is ill-defined consisting multiple tiny liver nodules spreading throughout the entire liver or entire liver lobe, without a dominant nodule ref.
MRI is the modality of choice with regards to infiltrative hepatocellular carcinoma, since they may be subtle and difficult to differentiate from liver cirrhosis with other modalities ref.
MRI
Signal characteristics
T1: homogeneously hypointense or heterogeneously hypointense in contrast to normal surrounding liver
-
T1 C+ (Gd):
-
arterial phase
in contrast with typical hepatocellular carcinoma, it shows minimal arterial enhancement, hypoenhancement or isoenhancement
a miliary pattern of enhancement has also been reported
-
venous and delayed phases
washout remains a feature of infiltrative HCC, although it may be more heterogeneous or irregular than its nodular counterpart
washout may be absent in up to 50% of cases, in contrast to 33% of nodular hepatocellular carcinoma 3
a reticular appearance of the tumor can be seen, possibly related to fibrosis
-
T2: usually appears slightly hyperintense in comparison to normal surrounding liver
DWI: may appear slightly hyperintense to normal surrounding liver
Malignant portal vein thrombosis is often seen with infiltrative hepatocellular carcinomas and sometimes may be mistaken as the only radiological finding due to:
the enhancement of the main infiltrative lesion being rather subtle
the associated liver perfusion changes may complicate the imaging interpretation
Treatment and prognosis
Infiltrative HCC carries a worse prognosis than the nodular subtype 1,4.
Differential diagnosis
The differential diagnosis of infiltrative hepatocellular carcinoma is different from that of "regular" hepatocellular carcinoma because of its conspicuous appearance. Main differential diagnoses include: